newsWith multiple catalysts coming up in late 2021, GlobalData reports…
21 July 2021 | By Anna Begley (European Pharmaceutical Review)
With multiple catalysts coming up in late 2021, GlobalData reports a boom in the field of personalised neoantigen immuno-oncology therapeutics.